Abstract
Purpose
This randomized study was designed to compare the effect of sacral neuromodulation with optimal medical therapy in patients with severe fecal incontinence.
Methods
Patients (aged 39–86 years) with severe fecal incontinence were randomized to have sacral nerve stimulation (SNS group; n = 60) or best supportive therapy (control; n = 60), which consisted of pelvic floor exercises, bulking agent, and dietary manipulation. Full assessment included endoanal ultrasound, anorectal physiology, two-week bowel diary, and fecal incontinence quality of life index. The follow-up duration was 12 months.
Results
The sacral nerve stimulation group was similar to the control group with regard to gender (F:M = 11:1 vs. 14:1) and age (mean, 63.9 vs. 63 years). The incidence of a defect of ≤ 120° of the external anal sphincter and pudendal neuropathy was similar between the groups. Trial screening improved incontinent episodes by more than 50 percent in 54 patients (90 percent). Full-stage sacral nerve stimulation was performed in 53 of these 54 “successful” patients. There were no septic complications. With sacral nerve stimulation, mean incontinent episodes per week decreased from 9.5 to 3.1 (P < 0.0001) and mean incontinent days per week from 3.3 to 1 (P < 0.0001). Perfect continence was accomplished in 25 patients (47.2 percent). In the sacral nerve stimulation group, there was a significant (P < 0.0001) improvement in fecal incontinence quality of life index in all four domains. By contrast, there was no significant improvement in fecal continence and the fecal incontinence quality of life scores in the control group.
Conclusions
Sacral neuromodulation significantly improved the outcome in patients with severe fecal incontinence compared with the control group undergoing optimal medical therapy.
Similar content being viewed by others
References
Nelson R, Norton N, Cautley F, Furner S. Community based prevalence of anal incontinence. JAMA 1995;274:559–61.
Campbell AJ, Reinken J, McCosh L. Incontinence in the elderly: prevalence and prognosis. Age Ageing 1985;14:65–70.
Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc 1999;47:837–41.
Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med 1992;326:1002–7.
Tjandra JJ, Milsom JW, Schroeder T, Fazio V. Endoluminal ultrasound is preferable to electromyography in mapping anal sphincter defect. Dis Colon Rectum 1993;36:689–92.
Tan JJ, Chan MK, Tjandra JJ. Evolving therapy for fecal incontinence. Dis Colon Rectum 2007;50:1950–67.
Wong WD, Congliosi SM, Spencer MP, et al. The safety and efficacy of the artificial bowel sphincter for fecal incontinence: results from a multicenter cohort study. Dis Colon Rectum 2002;45:1139–53.
Wexner SD, Baeten C, Bailey R, et al. Safety and efficacy of dynamic graciloplasty for fecal incontinence: report of a prospective, multicenter trial. Dis Colon Rectum 2000;43:743–51.
Tjandra JJ, Lim JF, Matzel K. Sacral nerve stimulation - an emerging treatment for faecal incontinence. ANZ J Surg 2004;74:1098–106.
Matzel KE, Kamm MA, Stosser M, et al. Sacral spinal nerve stimulation for faecal incontinence: multicentre study. Lancet 2004;363:1270–6.
Hetzer FH, Hahnloser D, Clavien P-A, Demartines N. Quality of life and morbidity after permanent sacral nerve stimulation for fecal incontinence. Arch Surg 2007;142:8–13.
Kenefick NJ, Nicholls RJ, Cohen RG, Kamm MA. Medium-term results of permanent sacral nerve stimulation for faecal incontinence. Br J Surg 2002;89:896–901.
Gourcerol G, Gallas S, Michot F, Denis P, Leroi AM. Sacral nerve stimulation in fecal incontinence: are there factors associated with success. Dis Colon Rectum 2007;50:3–12.
Conaghan P, Farouk R. Sacral nerve stimulation can be successful in patients with ultrasound evidence of external anal sphincter disruption. Dis Colon Rectum 2005;48:1610–4.
Rosen HR, Urbarz C, Holzer B, Novi G, Schiessel R. Sacral nerve stimulation as a treatment for fecal incontinence. Gastroenterology 2001;121:536–41.
Tjandra JJ, Sharma BR, McKirdy H, Lowndes RH, Mansel RE. Anorectal physiological testing in defaecatory disorders: a prospective study. ANZ J Surg 1994;64:322–6.
Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993;36:77–97.
Rockwood TH, Church JM, Fleshman JW et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000;43:9–16.
Ware JE, Kosinski M, Keller SD. SF-12: How to score the SF-12 Physical and Mental Health Summary Scales. Boston: The Health Institute, New England Medical Center, 1995.
Lowry AC, Simmang CL, Boulous P, et al. Consensus statement of definitions for anorectal physiology and rectal cancer. Colorectal Dis 2001;3:272–5.
Ooi BS, Tjandra JJ, Tang CL, Dwyer P, Carey M. Anorectal physiological testing before and after a successful sphincter repair: a prospective study. Colorectal Dis 2000;2:220–8.
Leroi AM, Parc Y, Lehur PA, et al. Efficacy of sacral nerve stimulation for fecal incontinence. Results of a multicenter double-blind crossover study. Ann Surg 2005;242:662–9.
Rothbarth J, Bemelman WA, Meijerink WJ. What is the impact of fecal incontinence on quality of life? Dis Colon Rectum 2001;44:67–71.
Tjandra JJ, Lim JF, Hiscock R, Rajendra P. Injectable silicone biomaterial for fecal incontinence caused by internal anal sphincter dysfunction is effective. Dis Colon Rectum 2004;47:2138–46.
Melenhorst J, Koch SM, Uludag O, van Gemert WG, Baeten CG. Sacral nerve modulation for faecal incontinence: repaired anal sphincter complex versus anal sphincter defect. Colorectal Dis 2006;8(4):1–2.
Altomare D, Rinaldi M, Petrolino M, et al. Permanent sacral nerve modulation for faecal incontinence and associated urinary disturbances. Int J Colorectal Dis 2004;19:203–20.
Leroi AM, Michot F, Grise P, Denis P. Effect of sacral nerve stimulation in patients with faecal and urinary incontinence. Dis Colon Rectum 2001;44:779–89.
Ganio E, Masin A, Ratto C, et al. Short-term sacral nerve stimulation for functional anorectal and urinary disturbances: results in 40 patients: evaluation of a new option for anorectal functional disorders. Dis Colon Rectum 2001;44:1261–7.
Matzel K, Bittorf B, Stadelmaier U, Hohenfellner M, Hohenberger W. Sakralnervstimulation in der Behandlung der Stuhlinkontinenz. Chirurg 2003;74:26–32.
Schurch B, Reilly I, Reitz A, Curt A. Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients. World J Urol 2003;20:319–22.
Matzel KE, Stadelmaier U, Gall FP. Direct electrostimulation of the sacral spinal nerves in diagnosis of anorectal function. Lang Arch Chirurgie 1995;380:184–8.
Matzel KE, Stadelmaier U, Hohenfellneer M, Gall FP. Electrical stimulation for the treatment of fecal incontinence. Lancet 1995;346:1124–7.
HiJaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H, Rackley R. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 2006;68:533–7.
Byrne CM, Solomon MJ, Young JM, Rex J, Merlino CL. Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum 2007;50:417–27.
Hetzer FH, Bieler A, Hahnloser D, Lohlein F, Clavien P-A, Demartines N. Outcome and cost analysis of sacral nerve stimulation for faecal incontinence. Br J Surg 2006;93:1411–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
*Deceased.
About this article
Cite this article
Tjandra*, J.J., Chan, M.K.Y., Yeh, C.H. et al. Sacral Nerve Stimulation is more Effective than Optimal Medical Therapy for Severe Fecal Incontinence: A Randomized, Controlled Study. Dis Colon Rectum 51, 494–502 (2008). https://doi.org/10.1007/s10350-007-9103-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-007-9103-5